I h,25-DihydroxyvitaminD3( a,25(OH)2D3) converted in the liver from lax-hydroxyvitamin D3(ho(OH)D3) (Fukushima et al., 1975) has been known to function in target tissues in binding to a specific cytosol receptor and transportation to the nucleus (Brumbaugh & Haussler, 1975) . Although it has been reported that the growth of some tumour cells is inhibited in vitro by Ix,25(OH)D3 (Colston et al., 1981; Abe et al., 1981) , its antitumour effect has been more recently demonstrated in vivo (Sato et al., 1982; Honma et al., 1983) . lcx(OH)D3 might be used as a new anticancer agent with a mode of action different from those currently used.
The purpose of this experiment was to examine the effect of lcx(OH)D3 in vivo on metastases and survival time of tumour-bearing rats.
Animals used were 9-to 12-week old male ACI/N rats. The neoplasm was the ascites hepatoma K-23 1 which was poorly differentiated and rapidly growing (Sato & Sato, 1983) . Animals were given water and standard rat chow ad libitum. After 106 tumour cells were transplanted s.c. into the right posterior dorsum of rats, they were divided at random into two groups which were administered vehicle and It(OH)D3, respectively. lx(OH)D3 (Chugai Pharmaceutical Co., Ltd., Tokyo) dissolved in medium chain triglyceride (ODO®) (Nishin Oil Mills, Ltd., Tokyo) was administered at a dose of 0.5 igkg-' into the stomach by a stomach tube daily from a day after inoculation to a day before killing. The animals were killed on Day 13, and primary tumour and right inguinal lymph node were weighed and the number of macroscopically visible metastases on the pulmonary surfaces counted. The survival times of rats bearing tumour treated consecutively for 22 days from a day after inoculation were also determined.
In a separate experiment the animals were inoculated i.m. with 2 x 105 cells into the right hind leg and were given the agents daily to a day before killing as above-mentioned. The animals were killed on Day 20 and metastases of lymph nodes and lungs were also examined.
The tumour tissues were fixed in 10% formalin solution and paraffin sections were stained with
For testing the significance of the differences between two groups the U-test, which is a ranking test used for comparison when distribution is not normal and variances are large, was used.
The primary tumour weight of rats treated with 1lo(OH)D3 was slightly reduced, but metastases of lungs and right inguinal lymph nodes were significantly inhibited (Table I & Figure 1) . Moreover, the prolongation of the life span of rats bearing tumour treated with 1a(OH)D3 was slight, but significantly different from the ODO group (Figure 2) .
In the i.m. implantation experiment because bilateral lumbar lymph nodes were enlarged and fused into one and invaded the retroperitoneum, on Figure 2 Percent survival of rats bearing tumour. Seven rats in each group were inoculated s.c. with 106 K-231 ascites hepatoma cells and were given la(OH) D3 (0.5 ugkg-1) or vehicle (ODO®) daily for 22 days from one day after tumour inoculation. The mean survival times were 27.1 +0.8 days in the lo(OH)D3 group (---) and 24.8 + 0.8 days in the ODO group ), respectively (P<0.05).
account of the delay before killing, they could not be quantitatively estimated. However, primary tumours and lumbar lymph nodes were not macroscopically different between both groups. The weight of right inguinal lymph nodes was slightly reduced, and the number of metastases to the lungs was significantly decreased in the lae(OH)D3 group (Table II) . Histologically, morphological changes in primary tumour and metastatic lesions were not found between the ODO and loe(OH)D3 groups (Figure 3) . These experiments demonstrated that lae(OH)D3
reduced the formation and development of metastases in the lungs and lymph nodes more than the growth of the primary tumour. Moreover it prolonged the survival time of rats bearing tumour for a few days (statistically significant). Since la,25(OH)D3 receptors in certain human cancer cell lines are commonly present, despite variability in receptor concentration (Frampton et al., 1982) It has been reported that la(OH)D3 suppresses proliferation and induces differentiation of Ml myeloid leukaemia cells in vitro (Abe et al., 1981) , and prolongs the life span of animals inoculated with them regardless of T-lymphocyte-mediated immune responses (Honma et al., 1983) . However, no information is available on the effect of loc(OH)D3 following oral administration on the growth of metastases except for our previous report (Sato et al., 1982) and the mechanism of inhibition of metastasis is not yet evident. Further work will be necessary to examine whether metastases are suppressed because lcx(OH)D3 arrests the release of tumour cells from the primary neoplasm or because their secondary implantation and development are impaired.
